PMC:3279418 / 316-663 JSONTXT 14 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T161 10-14 WDT denotes that
T162 15-17 VBZ denotes is
T163 18-31 VBN denotes characterized
T164 32-34 IN denotes by
T165 35-42 JJ denotes chronic
T166 43-56 JJ denotes proliferative
T167 57-67 NN denotes dermatitis
T168 68-71 CC denotes and
T169 72-84 VBD denotes dysregulated
T170 85-94 NN denotes secretion
T171 95-97 IN denotes of
T172 98-99 NNP denotes T
T173 100-107 CD denotes helper1
T174 108-109 -LRB- denotes (
T175 109-112 NN denotes Th1
T176 112-113 -RRB- denotes )
T177 114-117 CC denotes and
T178 118-121 JJ denotes Th2
T179 122-131 NNS denotes cytokines
T180 131-132 . denotes .
T181 133-136 DT denotes The
T182 137-145 JJ denotes cellular
T183 146-149 CC denotes and
T184 150-159 JJ denotes molecular
T185 160-170 NNS denotes mechanisms
T186 171-181 VBG denotes underlying
T187 182-186 DT denotes this
T188 187-199 JJ denotes inflammatory
T189 200-209 NN denotes phenotype
T190 210-216 VBP denotes remain
T191 217-224 JJ denotes elusive
T192 224-225 . denotes .
T193 226-235 JJ denotes Dendritic
T194 236-241 NNS denotes cells
T195 242-245 MD denotes may
T196 246-256 VB denotes contribute
T197 257-259 TO denotes to
T198 260-263 DT denotes the
T199 264-274 NN denotes initiation
T200 275-278 CC denotes and
T201 279-290 NN denotes progression
T202 291-293 IN denotes of
T203 294-297 DT denotes the
T204 298-307 NN denotes phenotype
T205 308-310 IN denotes of
T206 311-328 JJ denotes SHARPIN-deficient
T207 329-333 NNS denotes mice
T208 334-341 IN denotes because
T209 342-344 IN denotes of
R100 T184 T182 conj molecular,cellular
R101 T185 T190 nsubj mechanisms,remain
R102 T186 T185 acl underlying,mechanisms
R103 T187 T189 det this,phenotype
R104 T188 T189 amod inflammatory,phenotype
R105 T189 T190 nsubj phenotype,remain
R106 T190 T190 ROOT remain,remain
R107 T191 T190 acomp elusive,remain
R108 T192 T190 punct .,remain
R109 T193 T194 amod Dendritic,cells
R110 T194 T196 nsubj cells,contribute
R111 T195 T196 aux may,contribute
R112 T196 T196 ROOT contribute,contribute
R113 T197 T196 prep to,contribute
R114 T198 T199 det the,initiation
R115 T199 T197 pobj initiation,to
R116 T200 T199 cc and,initiation
R117 T201 T199 conj progression,initiation
R118 T202 T199 prep of,initiation
R119 T203 T204 det the,phenotype
R120 T204 T202 pobj phenotype,of
R121 T205 T204 prep of,phenotype
R122 T206 T207 amod SHARPIN-deficient,mice
R123 T207 T205 pobj mice,of
R124 T208 T196 prep because,contribute
R125 T209 T208 pcomp of,because
R77 T161 T163 nsubjpass that,characterized
R78 T162 T163 auxpass is,characterized
R80 T164 T163 agent by,characterized
R81 T165 T167 amod chronic,dermatitis
R82 T166 T167 compound proliferative,dermatitis
R83 T167 T164 pobj dermatitis,by
R84 T168 T167 cc and,dermatitis
R85 T169 T170 amod dysregulated,secretion
R86 T170 T167 conj secretion,dermatitis
R87 T171 T170 prep of,secretion
R88 T172 T173 compound T,helper1
R89 T173 T171 pobj helper1,of
R90 T174 T175 punct (,Th1
R91 T175 T170 appos Th1,secretion
R92 T176 T175 punct ),Th1
R93 T177 T170 cc and,secretion
R94 T178 T179 amod Th2,cytokines
R95 T179 T170 conj cytokines,secretion
R97 T181 T185 det The,mechanisms
R98 T182 T185 amod cellular,mechanisms
R99 T183 T182 cc and,cellular